Study: Diabetes raises mortality risk in cancer patients
Cancer patients with insulin-treated diabetes were four times more likely to die within a year of cancer diagnosis and had a fivefold increased odds of dying within five years of diagnosis compared with those without diabetes, a study revealed. Researchers also found patients on diabetes drugs alone had a 10% and 50% higher mortality risk two and five years after cancer diagnosis, respectively. The findings appear in Diabetologia. HealthDay News
(3/14)
|
CMS issues guidance for stage 2 meaningful use exemptions
Health care professionals and hospitals may qualify for an exemption to stage 2 meaningful use rules if they have experienced vendor-related EHR certification delays, according to guidance from the CMS. Professionals also can apply for an exemption due to unforeseen or uncontrollable circumstances, lack of control over the availability of certified EHR technology or a lack of face-to-face interaction. Professionals must submit hardship exemption applications by July 1; hospitals must do so by April 1. Health Data Management
(3/11)
|
|
Support DiabetesPro SmartBrief DiabetesPro SmartBrief is the daily e-news resource for 31,000 influential leaders in diabetes care. E-mail Aaron Kern for more information on advertising. |
|
|
|
Self-assessment program on exercise and diabetes -- free CME/CE opportunity
This self-assessment program consists of clinical problem-solving multiple choice questions and educational critiques. It is designed to objectively assess and strengthen your knowledge of diabetes and provide you with a better understanding of the relationship between exercise and diabetes. Credit is available for all health care professionals. Learn more about this module and other educational opportunities.
|
|
Nature uses as little as possible of anything."
-- Johannes Kepler, German mathematician and astronomer
|
|
|
Please contact one of our specialists for advertising opportunities,
editorial inquiries, job placements, or any other questions.
Mailing Address: SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
|
|
|